{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:03:21Z","timestamp":1776643401431,"version":"3.51.2"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2017,9,2]],"date-time":"2017-09-02T00:00:00Z","timestamp":1504310400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s00125-017-4417-x","type":"journal-article","created":{"date-parts":[[2017,9,2]],"date-time":"2017-09-02T06:12:20Z","timestamp":1504332740000},"page":"2486-2494","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Application of white blood cell SPECT\/CT to predict remission after a 6 or 12\u00a0week course of antibiotic treatment for diabetic foot osteomyelitis"],"prefix":"10.1007","volume":"60","author":[{"given":"Julien","family":"Vouillarmet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myriam","family":"Moret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Morelec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Michon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Dubreuil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,9,2]]},"reference":[{"key":"4417_CR1","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1093\/cid\/cis346","volume":"54","author":"BA Lipsky","year":"2012","unstructured":"Lipsky BA, Berendt AR, Cornia PB et al (2012) 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis 54:132\u2013173","journal-title":"Clin Infect Dis"},{"key":"4417_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1086\/383272","volume":"39","author":"WJ Jeffcoate","year":"2004","unstructured":"Jeffcoate WJ, Lipsky BA (2004) Controversies in diagnosing and managing osteomyelitis of the foot in diabetes. Clin Infect Dis 39:115\u2013122","journal-title":"Clin Infect Dis"},{"key":"4417_CR3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nrendo.2009.243","volume":"6","author":"FL Game","year":"2010","unstructured":"Game FL (2010) Management of osteomyelitis of the foot in diabetes mellitus. Nat Rev Endocrinol 6:43\u201347","journal-title":"Nat Rev Endocrinol"},{"key":"4417_CR4","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/0002-9343(87)90894-1","volume":"83","author":"DM Bamberger","year":"1987","unstructured":"Bamberger DM, Daus GP, Gerding DN (1987) Osteomyelitis in the feet of diabetic patients: long-term results, prognostic factors and the role of antimicrobial and surgical therapy. Am J Med 83:653\u2013660","journal-title":"Am J Med"},{"key":"4417_CR5","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/(SICI)1096-9136(199706)14:6<487::AID-DIA373>3.0.CO;2-Q","volume":"14","author":"P Venkatesan","year":"1997","unstructured":"Venkatesan P, Lawn S, Macfarlane RM, Fletcher EM, Finch RG, Jeffcoate W (1997) Conservative management of osteomyelitis in the feet of diabetic patients. Diabet Med 14:487\u2013490","journal-title":"Diabet Med"},{"key":"4417_CR6","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1001\/archinte.159.8.851","volume":"159","author":"D Pittet","year":"1999","unstructured":"Pittet D, Wyssa B, Herter-Clavel C, Kursteiner K, Vaucher J, Lew DP (1999) Outcome of diabetic foot infections treated conservatively: a retrospective cohort study with long-term follow-up. Arch Intern Med 159:851\u2013856","journal-title":"Arch Intern Med"},{"key":"4417_CR7","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1093\/jac\/48.6.927","volume":"48","author":"E Senneville","year":"2001","unstructured":"Senneville E, Yazdanpanah Y, Cazaubiel M et al (2001) Rifampicin-ofloxacin oral regimen for the treatment of mild to moderate diabetic foot osteomyelitis. J Antimicrob Chemother 48:927\u2013930","journal-title":"J Antimicrob Chemother"},{"key":"4417_CR8","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1177\/107110070602701003","volume":"27","author":"JM Embil","year":"2006","unstructured":"Embil JM, Rose G, Trepman E et al (2006) Oral antimicrobial therapy for diabetic foot osteomyelitis. Foot Ankle Int 27:771\u2013779","journal-title":"Foot Ankle Int"},{"key":"4417_CR9","doi-asserted-by":"publisher","first-page":"637","DOI":"10.2337\/dc07-1744","volume":"31","author":"E Senneville","year":"2008","unstructured":"Senneville E, Lombart A, Beltrand E et al (2008) Outcome of diabetic foot osteomyelitis treated non-surgically: a retrospective cohort study. Diabetes Care 31:637\u2013642","journal-title":"Diabetes Care"},{"key":"4417_CR10","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1007\/s00125-008-0976-1","volume":"51","author":"FL Game","year":"2008","unstructured":"Game FL, Jeffcoate WJ (2008) Primarily non-surgical management of osteomyelitis of the foot in diabetes. Diabetologia 51:962\u2013967","journal-title":"Diabetologia"},{"key":"4417_CR11","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1111\/j.1464-5491.2009.02828.x","volume":"26","author":"J Valabhji","year":"2009","unstructured":"Valabhji J, Oliver N, Samarasinghe D, Mali T, Gibbs RG, Gedroyc WM (2009) Conservative management of diabetic forefoot ulceration complicated by underlying osteomyelitis: the benefits of magnetic resonance imaging. Diabet Med 26:1127\u20131134","journal-title":"Diabet Med"},{"key":"4417_CR12","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1111\/dme.12445","volume":"31","author":"J Vouillarmet","year":"2014","unstructured":"Vouillarmet J, Morelec I, Thivolet C (2014) Assessing diabetic foot osteomyelitis remission with white blood cell SPECT\/CT imaging. Diabet Med 31:1093\u20131099","journal-title":"Diabet Med"},{"key":"4417_CR13","doi-asserted-by":"publisher","first-page":"789","DOI":"10.2337\/dc13-1526","volume":"37","author":"JL L\u00e1zaro-Mart\u00ednez","year":"2014","unstructured":"L\u00e1zaro-Mart\u00ednez JL, Arag\u00f3n-S\u00e1nchez J, Garc\u00eda-Morales E (2014) Antibiotics versus conservative surgery for treating diabetic foot osteomyelitis: a randomized comparative trial. Diabetes Care 37:789\u2013795","journal-title":"Diabetes Care"},{"key":"4417_CR14","doi-asserted-by":"publisher","first-page":"302","DOI":"10.2337\/dc14-1514","volume":"38","author":"A Tone","year":"2015","unstructured":"Tone A, Nguyen S, Devemy F et al (2015) Six-week versus twelve-week antibiotic therapy for nonsurgically treated diabetic foot osteomyelitis: a multicenter open-label controlled randomized study. Diabetes Care 38:302\u2013307","journal-title":"Diabetes Care"},{"key":"4417_CR15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/dmrr.2699","volume":"32","author":"BA Lipsky","year":"2016","unstructured":"Lipsky BA, Arag\u00f3n-S\u00e1nchez J, Diggle M et al (2016) IWGDF guidance on the diagnosis and management of foot infections in persons with diabetes. Diabetes Metab Res Rev 32:45\u201374","journal-title":"Diabetes Metab Res Rev"},{"key":"4417_CR16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1177\/1534734612474304","volume":"12","author":"FJ \u00c1lvaro-Afonso","year":"2013","unstructured":"\u00c1lvaro-Afonso FJ, L\u00e1zaro-Mart\u00ednez JL, Arag\u00f3n-S\u00e1nchez J, Garc\u00eda-Morales E, Cecilia-Matilla A, Beneit-Montesinos JV (2013) Interobserver and intraobserver reproducibility of plain X-rays in the diagnosis of diabetic foot osteomyelitis. Int J Low Extrem Wounds 12:12\u201315","journal-title":"Int J Low Extrem Wounds"},{"key":"4417_CR17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/dmrr.2700","volume":"32","author":"FL Game","year":"2016","unstructured":"Game FL, Attinger C, Hartemann A et al (2016) IWGDF guidance on use of interventions to enhance the healing of chronic ulcers of the foot in diabetes. Diabetes Metab Res Rev 32:75\u201383","journal-title":"Diabetes Metab Res Rev"},{"key":"4417_CR18","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1177\/1534734613486152","volume":"12","author":"M Michail","year":"2013","unstructured":"Michail M, Jude E, Liaskos C et al (2013) The performance of serum inflammatory markers for the diagnosis and follow-up of patients with osteomyelitis. Int J Low Extrem Wounds 12:94\u201399","journal-title":"Int J Low Extrem Wounds"},{"key":"4417_CR19","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/iwj.12545","volume":"14","author":"SA Asten Van","year":"2017","unstructured":"Van Asten SA, Nichols A, La Fontaine J, Bhavan K, Peters EJ, Lavery LA (2017) The value of inflammatory markers to diagnose and monitor diabetic foot osteomyelitis. Int Wound J 14:40\u201345","journal-title":"Int Wound J"},{"key":"4417_CR20","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/iwj.12574","volume":"14","author":"SA Asten Van","year":"2017","unstructured":"Van Asten SA, Jupiter DC, Mithani M, La Fontaine J, Davis KE, Lavery LA (2017) Erythrocyte sedimentation rate and C-reactive protein to monitor treatment outcomes in diabetic foot osteomyelitis. Int Wound J 14:142\u2013148","journal-title":"Int Wound J"},{"key":"4417_CR21","first-page":"110","volume":"24","author":"GD Graham","year":"1983","unstructured":"Graham GD, Lundy MM, Frederick RJ, Berger DE, O\u2019Brien AW, Brown TJ (1983) Predicting the cure of osteomyelitis under treatment: concise communication. Nucl Med 24:110\u2013113","journal-title":"Nucl Med"},{"key":"4417_CR22","first-page":"1015","volume":"29","author":"K McCarthy","year":"1988","unstructured":"McCarthy K, Velchik MG, Alavi A, Mandell GA, Esterhai JL, Goll S (1988) Indium-111-labeled white blood cells in the detection of osteomyelitis complicated by a pre-existing condition. J Nucl Med 29:1015\u20131021","journal-title":"J Nucl Med"},{"key":"4417_CR23","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1177\/107110070102200906","volume":"22","author":"H Wall Van der","year":"2001","unstructured":"Van der Wall H, Lunz D, Stanton F, Bruce W (2001) Prognostic value of 99mTc leukocyte scintigraphy in diabetic pedal osteomyelitis. Foot Ankle Int 22:720\u2013724","journal-title":"Foot Ankle Int"},{"key":"4417_CR24","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1001\/jama.1991.03470090080036","volume":"266","author":"LG Newman","year":"1991","unstructured":"Newman LG, Waller J, Palestro CJ et al (1991) Unsuspected osteomyelitis in diabetic foot ulcers. Diagnosis and monitoring by leukocyte scanning with indium in 111 oxyquinoline. J Am Med Assoc 266:1246\u20131251","journal-title":"J Am Med Assoc"},{"key":"4417_CR25","doi-asserted-by":"publisher","first-page":"S104","DOI":"10.1086\/383271","volume":"39","author":"BA Lipsky","year":"2004","unstructured":"Lipsky BA (2004) Medical treatment of the infected diabetic foot. Clin Infect Dis 39:S104\u2013S114","journal-title":"Clin Infect Dis"},{"key":"4417_CR26","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1111\/iwj.12433","volume":"13","author":"F Lazaga","year":"2016","unstructured":"Lazaga F, Van Asten SA, Nichols A et al (2016) Hybrid imaging with 99mTc-WBC SPECT\/CT to monitor the effect of therapy in diabetic foot osteomyelitis. Int Wound J 13:1158\u20131160","journal-title":"Int Wound J"},{"key":"4417_CR27","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.2967\/jnumed.108.059493","volume":"50","author":"L Filippi","year":"2009","unstructured":"Filippi L, Uccioli L, Giurato L, Schillaci O (2009) Diabetic foot infection: usefulness of SPECT\/CT for 99mTc-HMPAO-labeled leukocyte imaging. J Nucl Med 50:1042\u20131046","journal-title":"J Nucl Med"},{"key":"4417_CR28","first-page":"271","volume":"28","author":"J Fontaine La","year":"2016","unstructured":"La Fontaine J, Bhavan K, Lam K et al (2016) Comparison between Tc-99m WBC SPECT\/CT and MRI for the diagnosis of biopsy-proven diabetic foot osteomyelitis. Wounds 28:271\u2013278","journal-title":"Wounds"},{"key":"4417_CR29","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s00259-012-2327-1","volume":"40","author":"S Saeed","year":"2013","unstructured":"Saeed S, Zafar J, Khan B et al (2013) Utility of 99mTc-labelled antimicrobial peptide ubiquicidin (29-41) in the diagnosis of diabetic foot infection. Eur J Nucl Med Mol Imaging 40:737\u2013743","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4417_CR30","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.2337\/dc12-2108","volume":"36","author":"E Aslangul","year":"2013","unstructured":"Aslangul E, M'bemba J, Caillat-Vigneron N et al (2013) Diagnosing diabetic foot osteomyelitis in patients without signs of soft tissue infection by coupling hybrid 67Ga SPECT\/CT with bedside percutaneous bone puncture. Diabetes Care 36:2203\u20132210","journal-title":"Diabetes Care"},{"key":"4417_CR31","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1097\/MNM.0000000000000603","volume":"37","author":"A Rastogi","year":"2016","unstructured":"Rastogi A, Bhattacharya A, Prakash M et al (2016) Utility of PET\/CT with fluorine-18-fluorodeoxyglucose-labeled autologous leukocytes for diagnosing diabetic foot osteomyelitis in patients with Charcot's neuroarthropathy. Nucl Med Commun 37:1253\u20131259","journal-title":"Nucl Med Commun"},{"key":"4417_CR32","first-page":"2","volume":"16","author":"AF Zuluaga","year":"2002","unstructured":"Zuluaga AF, Galvis W, Jaimes F, Vespa O (2002) Lack of microbiological concordance between bone and non-bone specimens in chronic osteomyelitis: an observational study. BMC Infect Dis 16:2\u20138","journal-title":"BMC Infect Dis"},{"key":"4417_CR33","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1086\/597263","volume":"48","author":"E Senneville","year":"2009","unstructured":"Senneville E, Morant H, Descamps D et al (2009) Needle puncture and transcutaneous bone biopsy cultures are inconsistent in patients with diabetes and suspected osteomyelitis of the foot. Clin Infect Dis 48:888\u2013893","journal-title":"Clin Infect Dis"},{"key":"4417_CR34","first-page":"485","volume":"28","author":"JY Poirier","year":"2002","unstructured":"Poirier JY, Garin E, Derrien C et al (2002) Diagnosis of osteomyelitis in the diabetic foot with a 99mTc-HMPAO leucocyte scintigraphy combined with a 99mTc-MDP bone scintigraphy. Diabetes Metab 28:485\u2013490","journal-title":"Diabetes Metab"},{"key":"4417_CR35","first-page":"1908","volume":"47","author":"L Filippi","year":"2006","unstructured":"Filippi L, Schillaci O (2006) Usefulness of hybrid SPECT\/CT in 99mTc-HMPAO-labeled leukocyte scintigraphy for bone and joint infections. J Nucl Med 47:1908\u20131913","journal-title":"J Nucl Med"},{"key":"4417_CR36","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2967\/jnmt.106.035402","volume":"35","author":"NS Ballani","year":"2007","unstructured":"Ballani NS, Al-Huda FA, Khan HA et al (2007) The value of quantitative uptake of (99m)Tc-MDP and (99m)Tc-HMPAO white blood cells in detecting osteomyelitis in violated peripheral bones. J Nucl Med Technol 35:91\u201395","journal-title":"J Nucl Med Technol"},{"key":"4417_CR37","first-page":"987","volume":"38","author":"FL Datz","year":"1997","unstructured":"Datz FL, Seabold JE, Brown ML et al (1997) Procedure guideline for technetium-99m exametazime (HMPAO) labeled leukocyte scintigraphy for suspected infection\/inflammation. J Nucl Med 38:987\u2013990","journal-title":"J Nucl Med"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-017-4417-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-017-4417-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-017-4417-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T19:17:43Z","timestamp":1552677463000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-017-4417-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,2]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["4417"],"URL":"https:\/\/doi.org\/10.1007\/s00125-017-4417-x","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,2]]},"assertion":[{"value":"6 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The datasets generated and\/or analysed during the current study are available from the corresponding author on reasonable request.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"The authors declare that there is no duality of interest associated with this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Duality of interest"}},{"value":"JV conceptualised and designed the study, contributed to data analysis and interpretation, and wrote the manuscript. MM, PM, IM and JD contributed to the acquisition, analysis and interpretation of the data. All authors were involved in revising the manuscript critically for important intellectual content and for final approval of the version to be published. JV is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Contribution statement"}}]}}